Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 28 April, 2020

JP Morgan Sec LLC

Willis Towers Watson plc 8.3

RNS Number : 1738L
J.P. Morgan Securities LLC
28 April 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL 

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

27 April 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)


Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities

 748,231  0.58

1,227,164  0.95

(2) Derivatives (other than options)

 565,550  0.44

672,184  0.52

(3)Optionsandagreementstopurchase/sell



Total

 1,313,781  1.02

1,899,348  1.47

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (Note 5)

USD

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sale

81

100

500

5

1

2

2

900

81

6

7,721

300

8,604

32

 

81

81

4

91

5

900

81

4,800

8,604

3

86

32

174.9500

175.0000

175.3080

175.5900

175.6700

175.6900

175.7600

175.7853

175.8700

175.9000

175.9900

176.8275

177.2200

179.0600

 

174.9500

175.0666

175.5600

175.5750

175.5900

175.7853

175.8700

175.9900

177.2200

177.9600

178.1600

179.0600

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(Note 5) USD

Equity Swap

Sale

900

175.7853

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)








 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)




 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)




Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    NO

 

Dateofdisclosure

28 April 2020

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBVLFLBZLXBBE

a d v e r t i s e m e n t